Home › Glioma › Minnesota › Minneapolis
Glioma clinical trials in Minneapolis, MN
3 studies for Glioma are looking for participants at sites in and around Minneapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
RecruitingPhase 2
- Atrium Health Levine Cancer Institute, Minneapolis
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
RecruitingPhase 1
- Children's Minnesota, Minneapolis
CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young Adults
RecruitingPhase 1
- Children's Minnesota, Minneapolis
Glioma trials in other cities
- New York City, NY26 studies
- Houston, TX24 studies
- Boston, MA19 studies
- Washington, DC17 studies
- Philadelphia, PA15 studies
- Columbus, OH15 studies
- San Francisco, CA15 studies
- Miami, FL15 studies
- Durham, NC12 studies
- Chicago, IL12 studies
- Los Angeles, CA11 studies
- Aurora, CO10 studies
Other studies in Minneapolis
- Non-Small Cell Lung Cancer29 studies
- Breast Cancer23 studies
- Ovarian Cancer23 studies
- Prostate Cancer22 studies
- Heart Failure22 studies
- Cancer (all types)21 studies
- Endometrial Cancer20 studies
- Colorectal Cancer20 studies
- Lung Cancer20 studies
- Acute Myeloid Leukemia19 studies
- Parkinson's Disease17 studies
- Coronary Artery Disease15 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.